Patrick M. Schlievert
Fundador en Hennepin Life Sciences LLC .
Cargos activos de Patrick M. Schlievert
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Hennepin Life Sciences LLC
 Hennepin Life Sciences LLC Pharmaceuticals: MajorHealth Technology Hennepin Life Sciences LLC operates as a clinical-stage biotechnology company which focuses on identifying and developing antimicrobial therapeutics. It is advancing its novel antimicrobial, GML Gel, for local administration to prevent and treat CA-UTIs caused by ESKAPE pathogens in hospitals and long-term care centers. The company was founded by Patrick M. Schlievert, William Merrill Faulkner and Douglas Wicks in 2009 and is headquartered in Plymouth, MN. | Director/Miembro de la Junta | 01/01/2009 | - |
| Director Técnico/Científico/I+D | 01/01/2009 | - | |
| Fundador | 01/01/2009 | - |
Historial de carrera de Patrick M. Schlievert
Antiguos cargos conocidos de Patrick M. Schlievert.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
ImmuVen, Inc.
 ImmuVen, Inc. Drugstore ChainsRetail Trade ImmuVen, Inc. develops drugs to treat viral diseases and cancer. The firm develops biotherapeutics to treat cancer, infectious disease, and autoimmune disorders. It’s platform allows rapid selection and optimization of T cell receptors with high affinity to targets in cancer, infections, and autoimmune pathways. The company was founded by David Kranz and Patrick M Schlievert in November 2008 and is headquartered in Champaign, IL. | Fundador | 01/11/2008 | - |
Estadísticas
Internacional
| Estados Unidos | 3 |
Operativa
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Retail Trade | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
ImmuVen, Inc.
ImmuVen, Inc. Drugstore ChainsRetail Trade ImmuVen, Inc. develops drugs to treat viral diseases and cancer. The firm develops biotherapeutics to treat cancer, infectious disease, and autoimmune disorders. It’s platform allows rapid selection and optimization of T cell receptors with high affinity to targets in cancer, infections, and autoimmune pathways. The company was founded by David Kranz and Patrick M Schlievert in November 2008 and is headquartered in Champaign, IL. | Retail Trade |
Hennepin Life Sciences LLC
Hennepin Life Sciences LLC Pharmaceuticals: MajorHealth Technology Hennepin Life Sciences LLC operates as a clinical-stage biotechnology company which focuses on identifying and developing antimicrobial therapeutics. It is advancing its novel antimicrobial, GML Gel, for local administration to prevent and treat CA-UTIs caused by ESKAPE pathogens in hospitals and long-term care centers. The company was founded by Patrick M. Schlievert, William Merrill Faulkner and Douglas Wicks in 2009 and is headquartered in Plymouth, MN. | Health Technology |
